Literature DB >> 8738466

Ocular complication in congenital erythropoietic porphyria.

K Tanigawa1, N Takamura, K Nakata, S Nagataki, S Yamashita.   

Abstract

Congenital erythropoietic porphyria (CEP), classically known as "Günther disease', is an extremely rare autosomal recessively inherited disorder characterized by mutilating cutaneous photosensitivity and abnormal porphyrin heam biosynthesis in the bone marrow. So far there is no effective therapy for CEP. Because of severe cutaneous photosensitivity, treatment of CEP has mainly been focused upon the avoidance of sunlight and trauma of the skin to minimize skin symptoms. Recently we have encountered ocular complications, especially scleral involvement, in 5 CEP patients. From this point of view, we should pay attention not only to cutaneous symptoms but also to scleral involvement and ophthalmological examination is required to assess the quality of life of CEP patients.

Entities:  

Mesh:

Year:  1996        PMID: 8738466     DOI: 10.1159/000310704

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  4 in total

1.  Need for measurement of porphyrins in teardrops in patients with congenital erythropoietic porphyria.

Authors:  N Takamura; K Kurihara; S Yamashita; M Kondo
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

2.  Allogeneic corneoscleral limbus tissue transplantation for treatment of the necrosis in porphyria eye disease.

Authors:  Feng Yan; Yan Lu; Jie Yin; Feng Jiang; Zhen-Ping Huang
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

3.  Scleral necrosis in congenital erythropoietic porphyria: A case report and review of the literature.

Authors:  Shweta Agarwal; Parthopratim Dutta Majumder; Bhaskar Srinivasan; Geetha Iyer
Journal:  Oman J Ophthalmol       Date:  2015 Sep-Dec

4.  A Rare Case of Puberty Onset Congenital Erythropoietic Porphyria with Ophthalmological Manifestations.

Authors:  Mishra Debjani; Mukhopadhyay Somnath
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.